Evidence map›Paper›PMID 18974311›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2009

Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis.

Irina Malyukova, Karen F Murray, Chengru Zhu, Edgar Boedeker, Anne Kane, Kathleen Patterson, Jeffrey R Peterson, Mark Donowitz, Olga Kovbasnjuk

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 94 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Editorial: Interaction of PathogenicFrontiers in cellular and infection microbiology · 2021
    Article
  15. Molecular Biology ofToxins · 2020
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Irina MalyukovaDept. of Medicine, Division of Gastroenterology, 918 Ross Research Bldg., 720 Rutland Ave., Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Karen F Murray
Chengru Zhu
Edgar Boedeker
Anne Kane
Kathleen Patterson
Jeffrey R Peterson
Mark Donowitz
Olga Kovbasnjuk
Johns Hopkins University · US

Funding

Hopkins Digestive Diseases Research Development CenterR24DK064388 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI DONOWITZ, MARK · 2003 to 2010
$4.6M
Shiga toxin uptake mechanisms and intracellular actionR01DK058928 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI KOVBASNJUK, OLGA · 2003 to 2010
$1.2M
NIDDK NIH HHS R01DK58928NIDDK NIH HHS R24DK064388
6 · The paper itself

Abstract

Shiga toxin 1 and 2 production is a cardinal virulence trait of enterohemorrhagic Escherichia coli infection that causes a spectrum of intestinal and systemic pathology. However, intestinal sites of enterohemorrhagic E. coli colonization during the human infection and how the Shiga toxins are taken up and cross the globotriaosylceramide (Gb3) receptor-negative intestinal epithelial cells remain largely uncharacterized. We used samples of human intestinal tissue from patients with E. coli O157:H7 infection to detect the intestinal sites of bacterial colonization and characterize the distribution of Shiga toxins. We further used a model of largely Gb3-negative T84 intestinal epithelial monolayers treated with B-subunit of Shiga toxin 1 to determine the mechanisms of non-receptor-mediated toxin uptake. We now report that E. coli O157:H7 were found at the apical surface of epithelial cells only in the ileocecal valve area and that both toxins were present in large amounts inside surface and crypt epithelial cells in all tested intestinal samples. Our in vitro data suggest that macropinocytosis mediated through Src activation significantly increases toxin endocytosis by intestinal epithelial cells and also stimulates toxin transcellular transcytosis. We conclude that Shiga toxin is taken up by human intestinal epithelial cells during E. coli O157:H7 infection regardless of the presence of bacterial colonies. Macropinocytosis might be responsible for toxin uptake by Gb3-free intestinal epithelial cells and transcytosis. These observations provide new insights into the understanding of Shiga toxin contribution to enterohemorrhagic E. coli-related intestinal and systemic diseases.

Indexed as

EndocytosisPinocytosisActinsAnimalscdc42 GTP-Binding ProteinCell LineCell MembraneChlorpromazineClathrinDisease Models, AnimalEnzyme ActivationEpithelial CellsEscherichia coli InfectionsEscherichia coli O157EthylmaleimideHumansActinscdc42 GTP-Binding ProteinChlorpromazineClathrinEthylmaleimideglobotriaosylceramideN-Ethylmaleimide-Sensitive ProteinsRecombinant ProteinsShiga Toxin 1Shiga Toxin 2src-Family KinasesTetradecanoylphorbol AcetateTrihexosylceramides

Identifiers

PMID18974311
PMCPMC2636932
OpenAlexW2148902533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.